August 21, 2012 - The popular blood thinner Pradaxa has been associated with severe and sometimes fatal internal bleeding. Now, those patients affected will have the right to seek recovery after a federal judge ruled lawsuits against the manufacturer can proceed.
Anyone who has suffered internal bleeding or had a loved one affected by taking Pradaxa is encouraged to speak with a lawyer about their legal rights as soon as possible.
Pradaxa is a popular anticoagulant drug prescribed to stop strokes and blood clots in patients with atrial fibrillation. The manufacturer, German drug company Boehringer Ingelheim, has already earned over $1 billion selling it in the few short years it has been on the market.
However, the FDA announced on December 7, 2011 that they were investigating the drug’s safety after receiving more injury or death reports from Pradaxa than expected. This came after the drug maker admitted receiving more than 260 reports of internal bleeding death among users.
The Institute for Safe Medication Practices also reported on June 6, 2012 that Pradaxa led all medications in 2011 for reports of death or bleeding.
Due to the number of Pradaxa lawsuits expected over beeding or death, a federal panel recently established a central court in Illinois to handle the claims.
On July 25th, Judge David Herndon issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits. He ruled that while the drug label warned of internal bleeding, it did not mention the risk of uncontrollable bleeding and the lack of a reversal agent.
Those who have been affected by Pradaxa bleeding now have the right to file claims. Anyone affected should speak with a lawyer as soon as possible.
Victims should only choose someone with experience in this type of litigation. The Pradaxa Resource center works only with lawyers who are already handling Pradaxa lawsuits.
Contact us today for more information on the drug Pradaxa, or to speak with a lawyer.